Nrx pharmaceuticals closes $11 million unsecured debt financing

Radnor, pa. , nov. 7, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals" or the "company"), a clinical-stage cns biopharmaceutical company, today announced that it has obtained approximately $11 million in unsecured debt financing (the "note") from streeterville capital, llc, a utah limited liability company.

NRXP Ratings Summary

NRXP Quant Ranking